Bo Ma

3.0k total citations · 1 hit paper
84 papers, 2.2k citations indexed

About

Bo Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bo Ma has authored 84 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 35 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Bo Ma's work include Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (9 papers) and Immunotherapy and Immune Responses (8 papers). Bo Ma is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (9 papers) and Immunotherapy and Immune Responses (8 papers). Bo Ma collaborates with scholars based in China, United States and Netherlands. Bo Ma's co-authors include Alan Wells, Amanda M. Clark, Rui Cao, Ye Tian, Lushun Yuan, Gang Wang, Sarah Wheeler, Jelena Grahovac, Douglas A. Lauffenburger and Bea Christen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bo Ma

81 papers receiving 2.2k citations

Hit Papers

Dabrafenib in patients with BRAFV600E-positive advanced n... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ma China 24 1.1k 932 668 655 285 84 2.2k
Duane H. Hamilton United States 25 726 0.6× 1.2k 1.3× 440 0.7× 335 0.5× 876 3.1× 49 2.2k
William McCulloch United States 21 1.4k 1.2× 484 0.5× 226 0.3× 512 0.8× 277 1.0× 87 2.5k
J.M. Jurado Spain 33 2.3k 2.1× 893 1.0× 308 0.5× 1.4k 2.1× 159 0.6× 72 3.4k
C. Marcela Díaz‐Montero United States 27 837 0.7× 1.8k 1.9× 476 0.7× 318 0.5× 2.0k 7.0× 83 3.4k
Feng Xie China 22 2.0k 1.8× 458 0.5× 226 0.3× 784 1.2× 548 1.9× 50 2.7k
Mihai Gagea United States 27 1.6k 1.4× 506 0.5× 154 0.2× 784 1.2× 363 1.3× 62 2.4k
Romain Remark France 18 750 0.7× 1.9k 2.0× 520 0.8× 316 0.5× 1.7k 6.0× 33 3.1k
Ruozhen Hu United States 20 2.1k 1.8× 1.1k 1.1× 304 0.5× 1.1k 1.7× 1.2k 4.2× 26 3.4k
Elie Marcheteau France 12 594 0.5× 1.5k 1.6× 466 0.7× 345 0.5× 1.0k 3.7× 20 2.4k
Prafulla C. Gokhale United States 24 1.4k 1.2× 779 0.8× 318 0.5× 319 0.5× 358 1.3× 84 2.4k

Countries citing papers authored by Bo Ma

Since Specialization
Citations

This map shows the geographic impact of Bo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ma more than expected).

Fields of papers citing papers by Bo Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ma. The network helps show where Bo Ma may publish in the future.

Co-authorship network of co-authors of Bo Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ma. A scholar is included among the top collaborators of Bo Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ma. Bo Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Liang, Xiao Liu, Jie Yu, et al.. (2025). Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS/CALR/Caspase-3/GSDME pathway. Journal of Advanced Research. 77. 669–688. 4 indexed citations
2.
Yang, Feng, Fei Chen, Chenglong Mu, et al.. (2025). M1 macrophages enhance breast cancer chemoresistance via JAK-STAT3 signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1872(1). 168056–168056. 2 indexed citations
3.
Luo, Rui, Yang Li, Shijie Wang, et al.. (2025). Partial cystectomy as a surgical option for colorectal cancer patients with pathological bladder invasion: an original retrospective study. Therapeutic Advances in Gastroenterology. 18. 1118491363–1118491363.
4.
Ma, Bo, et al.. (2024). Study of perforated well productivity by a multi-scale coupling flow model with Darcy-brinkman-Navier/Stokes. Geoenergy Science and Engineering. 243. 213377–213377. 3 indexed citations
5.
Li, Meng, Bo Ma, Jinyu Liu, et al.. (2024). A Senescence-Associated Secretory Phenotype of Bone Marrow Mesenchymal Stem Cells Inhibits the Viability of Breast Cancer Cells. Stem Cell Reviews and Reports. 20(4). 1093–1105. 3 indexed citations
8.
Li, Hanqing, Xin Wang, Junwei Wang, et al.. (2023). Duck gasdermin E is a substrate of caspase-3/-7 and an executioner of pyroptosis. Frontiers in Immunology. 13. 1078526–1078526. 8 indexed citations
9.
Chen, Fei, Xiang Li, Liang Chen, et al.. (2023). Ginsenosides and Ginseng Phenolic Acids Relieve Ionizing Radiation-Induced Pyroptosis and Apoptosis in Intestinal Epithelial Cells. Natural Product Communications. 18(8). 1 indexed citations
11.
Ma, Bo, Pei Cao, Lichen Zhang, et al.. (2023). YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation. Heliyon. 9(8). e18876–e18876. 5 indexed citations
12.
Ma, Bo, Zaoqu Liu, Hui Xu, et al.. (2022). Molecular Characterization and Clinical Relevance of ALDH2 in Human Cancers. Frontiers in Medicine. 8. 832605–832605. 8 indexed citations
13.
Li, Lu, et al.. (2020). Laparoscopic transmesenteric pyeloplasty and isthmusectomy for adult horseshoe kidney with recurrent symptomatic hydronephrosis. SHILAP Revista de lepidopterología. 3(5). 220–222. 2 indexed citations
14.
Cao, Rui, Lushun Yuan, Bo Ma, Gang Wang, & Ye Tian. (2020). Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC). Cancer Immunology Immunotherapy. 70(1). 1–18. 73 indexed citations
15.
Ma, Bo, Alan Wells, & Amanda M. Clark. (2019). The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment. Seminars in Cancer Biology. 60. 138–147. 36 indexed citations
16.
Li, Jing, et al.. (2017). DIP2C expression in breast cancer and its clinical significance. Pathology - Research and Practice. 213(11). 1394–1399. 9 indexed citations
17.
Ma, Bo, Qianqian Ma, Chunhui Jin, et al.. (2015). ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.. PubMed. 8(10). 13279–83. 13 indexed citations
18.
Nathanson, Katherine L., Anne‐Marie Martin, Bradley Wubbenhorst, et al.. (2013). Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436). Clinical Cancer Research. 19(17). 4868–4878. 132 indexed citations
19.
Wells, Alan, Jelena Grahovac, Sarah Wheeler, Bo Ma, & Douglas A. Lauffenburger. (2013). Targeting tumor cell motility as a strategy against invasion and metastasis. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
20.
Ma, Bo, Hanfang Jiang, Jun Jia, et al.. (2012). Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells. Clinical & Translational Oncology. 14(10). 764–773. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026